An updated meta-analysis of the Fc receptor-like 3 -169T/C polymorphism and rheumatoid arthritis risk

Scandinavian Journal of Rheumatology

Volumn 42, Issue 4, 2013, Pages 270-275

  Nong, L M ^a   Ren, K W ^b   Mi, Y Y ^c   Xu, N W ^a   Zhou, D ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^c NANTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; RHEUMATOID FACTOR;

ARTICLE; ASIAN; CAUCASIAN; COMPARATIVE STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GENETIC ASSOCIATION; GENETIC MODEL; HEALTH HAZARD; HOMOZYGOTE; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PUBLISHING; RHEUMATOID ARTHRITIS; SENSITIVITY ANALYSIS;

ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; RECEPTORS, IMMUNOLOGIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 84880197440     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2012.754938     Document Type: Article

References (37)

1. Gabriel SE, Crowson CS, O'Fallon WM. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. Arthritis Rheum 1999;42:415-20. (Pubitemid 29136087)
2. Barton A, Thomson W, Ke X, Eyre S, Hinks A, Bowes J, et al. Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13. Nat Genet 2008;40:1156-9.
3. Orozco G, Rueda B, Martin J. Genetic basis of rheumatoid arthritis. Biomed Pharmacother 2006;60:656-62.
4. Coenen MJ, Gregersen PK. Rheumatoid arthritis: A view of the current genetic landscape. Genes Immun 2009;10:101-11.
5. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-61. (Pubitemid 40852711)
6. Davis RS. Fc receptor-like molecules. Annu Rev Immunol 2007;25:525-60. (Pubitemid 46697916)
7. Kochi Y, Yamada R, Suzuki A, Harley JB, Shirasawa S, Sawada T, et al. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 2005;37:478-85. (Pubitemid 40617275)
8. Gibson AW, Li FJ, Wu J, Edberg JC, Su K, Cafardi J, et al. The FCRL3-169CT promoter single-nucleotide polymorphism, which is associated with systemic lupus erythematosus in a Japanese population, predicts expression of receptor protein on CD19+ B cells. Arthritis Rheum 2009;60:3510-12.
9. LeeYH, Woo JH, Choi SJ, Ji JD, Song GG. Fc receptor-like 3 -169 C/T polymorphism and RA susceptibility: A meta-analysis. Rheumatol Int 2010;30:947-53.
10. Begovich AB, Chang M, Schrodi SJ. Meta-analysis evidence of a differential risk of the FCRL3 -169T->C polymorphism in white and East Asian rheumatoid arthritis patients. Arthritis Rheum 2007;56:3168-71. (Pubitemid 47502766)
11. Takata Y, Inoue H, Sato A, Tsugawa K, Miyatake K, Hamada D, et al. Replication of reported genetic associations of PADI4, FCRL3, SLC22A4 and RUNX1 genes with rheumatoid arthritis: Results of an independent Japanese population and evidence from meta-analysis of East Asian studies. J Hum Genet 2008; 53:163-73.
12. Wu H, Yang LH, Zuo J, Liang YL, Li PQ, Liu W, et al. Fc receptor-like 3 gene polymorphisms confer susceptibility to rheumatoid arthritis in a Chinese population. Hum Immunol 2010;71:1203-8.
13. MaehlenMT,NordangGB, Syversen SW, van der HeijdeDM,Kvien TK, Uhlig T, et al. FCRL3 -169C/C genotype is associated with anticitrullinated protein antibody-positive rheumatoid arthritis and with radiographic progression. J Rheumatol 2011;38: 2329-35.
14. El-Gabalawy HS, Robinson DB, Daha NA, Oen KG, Smolik I, Elias B, et al. Non-HLA genes modulate the risk of rheumatoid arthritis associated with HLA-DRB1 in a susceptible North American Native population. Genes Immun 2011;12:568-74.
15. Han SW, Sa KH, Kim SI, Lee SI, Park YW, Lee SS, et al. FCRL3 gene polymorphisms contribute to the radiographic severity rather than susceptibility of rheumatoid arthritis. Hum Immunol 2012;73:537-42.
16. Chen JY, Wang CM, Wu YJ, Kuo SN, Shiu CF, Chang SW, et al. Disease phenotypes and gender association of FCRL3 single-nucleotide polymorphism -169T/C in Taiwanese patients with systemic lupus erythematosus and rheumatoid arthritis. JRheumatol 2011;38:264-70.
17. Ikari K, Momohara S, Nakamura T, Hara M, Yamanaka H, Tomatsu T, et al. Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis. Ann Rheum Dis 2006;65:671-3.
18. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
19. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88. (Pubitemid 17189972)
20. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997;315:629-34. (Pubitemid 27387172)
21. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
22. Eike MC, Nordang GB, Karlsen TH, Boberg KM, Vatn MH; IBSEN study group, et al. The FCRL3 -169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases. Ann Rheum Dis 2008;67:1287-91.
23. Owen CJ, Kelly H, Eden JA, Merriman ME, Pearce SH, Merriman TR. Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association. J Clin Endocrinol Metab 2007;92:1106-11. (Pubitemid 46465689)
24. Thabet MM, Wesoly J, Slagboom PE, Toes RE, Huizinga TW. FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians. Ann Rheum Dis 2007;66:803-6. (Pubitemid 46846701)
25. Hu X, Chang M, Saiki RK, Cargill MA, Begovich AB, Ardlie KG, et al. The functional -169T->C single-nucleotide polymorphism in FCRL3 is not associated with rheumatoid arthritis in white North Americans. Arthritis Rheum 2006;54:1022-5.
26. Eyre S, Bowes J, Potter C, Worthington J, Barton A. Association of the FCRL3 gene with rheumatoid arthritis: A further example of population specificity? Arthritis Res Ther 2006;8:R117.
27. Newman WG, Zhang Q, Liu X, Walker E, Ternan H, Owen J, et al. Rheumatoid arthritis association with the FCRL3 -169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population. Arthritis Rheum 2006;54:3820-7. (Pubitemid 44955883)
28. Choi CB, Kang CP, Seong SS, Bae SC, Kang C. The -169C/T polymorphism in FCRL3 is not associated with susceptibility to rheumatoid arthritis or systemic lupus erythematosus in a case-control study of Koreans. Arthritis Rheum 2006;54: 3838-41. (Pubitemid 44955885)
29. Martínez A, Sánchez E, Valdivia A, Orozco G, López-Nevot MA, Pascual-Salcedo D, et al. Epistatic interaction between FCRL3 and NFkappaB1 genes in Spanish patients with rheumatoid arthritis. Ann Rheum Dis 2006;65:1188-91. (Pubitemid 44277394)
30. Salmon JE, Pricop L. Human receptors for immunoglobulin G: Key elements in the pathogenesis of rheumatic disease. Arthritis Rheum 2001;44:739-50. (Pubitemid 32319766)
31. Nimmerjahn F, Ravetch JV. Fcgamma receptors: Old friends and new family members. Immunity 2006;24:19-28. (Pubitemid 43077197)
32. Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol 2001;19:275-90. (Pubitemid 32368037)
33. Berglin E, Kokkonen H, Einarsdottir E, Agren A, Rantapää Dahlqvist S. Influence of female hormonal factors, in relation to autoantibodies and genetic markers, on the development of rheumatoid arthritis in northern Sweden: A case-control study. Scand J Rheumatol 2010;39:454-60.
34. Dziedziejko V, Kurzawski M, Safranow K, Drozdzik M, Chlubek D, Pawlik A. Oestrogen receptor polymorphisms in female patients with rheumatoid arthritis. Scand J Rheumatol 2011;40:329-33.
35. Tamai M, Kawakami A, Iwamoto N, Arima K, Aoyagi K, Eguchi K. Contribution of anti-CCP antibodies, proximal interphalangeal joint involvement, HLA-DRB1 shared epitope, and PADI4 as risk factors for the development of rheumatoid arthritis in palindromic rheumatism. Scand J Rheumatol 2010;39:287-91.
36. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-78.
37. Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010;42:508-14.